Clinical trial
Antimicrobial PK in Infants With Suspected or Confirmed Infection
NCT00491426 · Duke University, Other · Completed
Key facts
| NCT number | NCT00491426 |
|---|---|
| Title | Antimicrobial PK in Infants With Suspected or Confirmed Infection |
| Official title | Antimicrobial Pharmacokinetics in High Risk Infants (Urinary Proteomics in Antimicrobial/Antifungal-Treated Newborns - add-on Study) |
| Lead sponsor | Duke University, Other |
| Collaborators | Pediatric Pharmacology Research Units Network |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection |
| Intervention type | Drug |
| Interventions | Ampicillin, Metronidazole, Piperacillin/Tazobactam, Acyclovir, Amphotericin B, Ambisome, Anidulafungin, Caspofungin |
| Enrollment | 450 |
| Start date | Jan 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jun 26, 2007 |
| Last update posted | Nov 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: